National Antibiotic Allergy Network

NAAN Purpose:

The National Antibiotic Allergy Network (NAAN) is a collaborative group of mixed discipline clinicians and policy makers related to antibiotic allergy. The NAAN Committee has representatives from each state and territory representing AMS activities. The Committee has further representation from key allergy and AMS clinicians, societies, and research centres.  The NAAN committee reports to the AMS Jurisdiction Network.

Key Objectives:

The NAAN provides a repository of consumer and clinician antibiotic allergy protocols, policies and procedures, that can be disseminated and implemented nationally, in particular to aid sites with limited resources or experience with antibiotic allergy.  

The NAAN Committee and its members will be a resource for support for health services in the establishment and implementation of antibiotic allergy programs, focused on the delivery of criteria set out in the National Safety and Quality Health Service (NSQHS) Standards - Standard 3.

The NAAN Committee will also provide a framework for collaborative health services research in antibiotic allergy and the formation of a registry for antibiotic allergy testing, to enable sites access to individual data for safety and monitoring purposes. 

Key Projects:

1. International Network of Antibiotic Allergy Nations (iNAAN) Study - Penicillin Allergy Delabelling via Direct Oral Challenge

2. Clinical and consumer information and protocols

3. Antibiotic allergy advocacy and policy

International Network of Antibiotic Allergy Nations (iNAAN)

This is an international project initially focused on the collection of penicillin allergy assessment and/or oral challenge data in the inpatient setting. The project utilises a point-of-care smartphone device which was adapted from the published Antibiotic Allergy Assessment Tool and PEN-FAST to provide clinicians with a platform to easily collect penicillin allergy phenotypic data and enable a resultant risk-assessment. The app also allows oral challenge data collection at point-of-care. This data is automatically linked with a central REDCap database hosted by BioGrid Australia. This project has Austin Health Ethics (HREC) approval (HREC/78719/Austin-21). This is supported by NAAN and CAAR and is currently in the site enrolment phase from health services across Australia and internationally. The focus of this study is to collect penicillin allergy data to inform national guidelines, policy and AMS practice. 

Further information: Please contact the iNAAN Project Manager Ms. Elise Mitri  - naan@austin.org.au